Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 May 1;69(1):119–125. doi: 10.1097/QAI.0000000000000555

Figure 2.

Figure 2

Percent of new infections averted plotted against the population percent reduction in per-contact risk (PRPCR) in the targeted population (L) and person-years on PrEP per infection averted by targeting strategy (R) for scenarios in Peru.